-
Published17/10/2024
-
Deadline19/11/2024
-
Opening of tenders19/11/2024
-
Today27/08/2026
Utilities
- indicates text translated automatically in your browsing language
Immune medicinal products (immunoglobulins)
The contracting authority shall provide for the purchase of immunological medicinal products: - i Immunoserum (immunoglobulin) for the treatment of diphtheria; - ii Human tetanus immunoglobulin or Human anti-tetanus immunosera. The requirements for the subject-matter of the contract are set out in Annex 2 ‘Technical specification’ to the HS.
https://pirkimai.eviesiejipirkimai.lt/app/rfq/rwlentrance_s.asp?PID=786593&B=
https://pirkimai.eviesiejipirkimai.lt/app/rfq/rwlentrance_s.asp?PID=786593&B=
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.